Checkpoint blockade therapies have improved cancer treatment, but such immunotherapy
regimens fail in a large subset of patients. Conventional type 1 dendritic cells (DC1s) control …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an …

Macrophages have a key role in shaping the tumour microenvironment (TME), tumour
immunity and response to immunotherapy, which makes them an important target for cancer …

Background & Aims Given that gastrointestinal (GI) symptoms are a prominent extrapulmonary
manifestation of COVID-19, we investigated intestinal infection with SARS-CoV-2, its …

A damaging inflammatory response is implicated in the pathogenesis of severe coronavirus
disease 2019 (COVID-19), but mechanisms contributing to this response are unclear. In two …

Photodynamic therapy (PDT) utilizes a sensitizer agent and light to produce selective cell
death. Dermatologists are familiar with PDT for the treatment of actinic keratoses and early …

Cutaneous malignant melanoma (CMM) has been increasing steadily in incidence during
the past 30 years. Recent studies have explored associations between CMM and varying …

Background— The Dietary Approaches to Stop Hypertension (DASH) diet is recommended
in the 2005 US Dietary Guidelines. To understand the potential benefits of DASH on …

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
conditions with high morbidity and mortality. Supportive care management of SJS/TEN is …

Dermatologists treating immune-mediated skin disease must now contend with the uncertainties
associated with immunosuppressive use in the context of the severe acute respiratory …